Abstract
Purpose
Anti-cancer therapy put patients in an immunocompromised status. Reactivation of cytomegalovirus (CMV) in immunocompromised patient can cause a severe disease. Thus, we presented a case who had recurrent CMV colitis which complicate with rectovaginal fistula.
Methods
We present a case of everolimus-associated cytomegalovirus colitis on a patient receiving everolimus and exemestane therapy for the treatment of metastasized breast cancer.
Results
The patient presented septic shock and acute peritonitis at first. Emergency exploratory laparotomy was performed. However, only edematous changes were observed over the terminal ileum, sigmoid colon and rectum. Four weeks after operation, we found feces coming out from her vagina. Colonoscopy was done and revealed rectovaginal fistula. Colonic and rectal mucosa moderate inflammation with multiple ulcer was also noted. Biopsy was done and the pathology proved CMV colitis. After treatment with ganciclovir, her symptoms improved. Everolimus was stopped for 12 weeks and was added back with a decreasing dose paradigm for breast cancer treatment. However, another episode of CMV colitis occurred again after resuming the everolimus. After anti-virus treatment, she was discharged. Due to adverse effects, everolimus therapy was discontinued.
Conclusion
The standard treatment of hormone receptor positive and HER-2 negative metastatic breast cancer is everolimus together with exemestane. Due to the immunosuppressive effects of everolimus, the medication may cause invasive fungal infection or other opportunistic infections. Such infections are serious and may even be fatal. In this case, we did not consider CMV infection until rectovaginal fistula formation. Thus, for solid cancer patients presented with fever of unknown origin, clinicians should consider potential complications of CMV infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harano Y, Kotajima L, Arioka H. Case of cytomegalovirus colitis in an immunocompetent patient: a rare cause of abdominal pain and diarrhea in the elderly. Int J Gen Med. 2015;8:97–100.
Cannon MJ, Scott Schmid D, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13. https://doi.org/10.1002/rmv.655.
Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries. 2011;5(8):571–9.
Schlick K, Grundbichler M, Auberger J, et al. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015. https://doi.org/10.1186/s13027-015-0039-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Yang has nothing to disclose. Dr. Shao has nothing to disclose.
Ethical approval
The manuscript has not been submitted to more than one journal for simultaneous consideration. The manuscript has not been published previously. All authors have seen the manuscript and approved to submit to your journal.
Informed consent
Informed consent was obtained from the patient in the case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yang, JR., Shao, YC. Everolimus-associated cytomegalovirus colitis in a patient with metastasized breast cancer: a case report. Breast Cancer 27, 776–779 (2020). https://doi.org/10.1007/s12282-019-01026-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-019-01026-6